No phaseRecruiting
Efficacy of Human Placental Membrane Products and Standard of Care in the Management of Nonhealing Diabetic Foot Ulcers and Venous Leg Ulcers (BIORESCUE)
A Multicenter, Prospective, Controlled Modified Multi-Platform Trial Assessing the Efficacy of Human Placental Membrane Products and Standard of Care in the Management of Nonhealing Diabetic Foot Ulcers and Venous Leg Ulcers
- Sponsor
- BioLab Holdings (Industry)
- Enrolment
- 50 planned
- Conditions
- Diabetic Foot Ulcer; Foot Ulcer Chronic; DFU; Ulcer Foot; Venous Leg Ulcer (VLU); Venous Leg Ulcer; Venous Ulcer; Leg Ulcers; Ulcer
- Interventions
- Tri-Membrane Wrap™ DFU; Membrane Wrap™ DFU; Membrane Wrap-Lite™ DFU; Membrane Wrap-Hydro™ DFU; Tri-Membrane Wrap™ VLU; Membrane Wrap™ VLU; Membrane Wrap-Lite™ VLU; Membrane Wrap-Hydro™ VLU
- Ages
- adults, older adults
- Registry
- NCT07364630
Full record on ClinicalTrials.gov
From the registry
The study is a multicenter, prospective, controlled modified multi-platform trial assessing the efficacy of human placental membrane products and standard of care in the management of nonhealing diabetic foot ulcers and venous leg ulcers.
Primary outcomes
- Percentage of Wound Closure
History
Primary completion expected
Last registry update
Registered
Started